Brexit: A Bane for Bumbling Biotech ETFs?

Brexit is the excuse of the moment that many market observers are pointing to explain the near-term struggles of various asset classes and sectors. In some cases, that observation is accurate. In others, it lacks merit. If there is a silver lining, it could be that some sectors are being unjustly...